Siegfried reaches manufacturing, supply agreement with Keryx

Siegfried and Keryx Biopharmaceuticals Inc have entered into a master manufacturing services and supply agreement. Under the agreement, Siegfried will perform certain manufacturing activities at its manufacturing facilities in Saint Vulbas, France and Pennsville, New Jersey as well as to manufacture and supply GMP-grade quantities of the proprietary active pharmaceutical ingredient for Keryx’s drug product, Auryxia.

Read more: Siegfried reaches manufacturing, supply agreement with Keryx

One clap, two clap, three clap, forty?

By clapping more or less, you can signal to us which stories really stand out.